• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Home
  • LinkedIn
  • Twitter

  • About Us
    • Overview
    • Executive Committee
    • Board Of Directors
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • shRNA
      • shARC Platform
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Careers
  • Contact Us
  • Home
  • Investors
  • Regulated Information

Regulated Information

Financial Reports

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

23

Mar
2023

Annual Report 2022

  • FR

  • FR


24

Mar
2022

Annual Report 2021

  • FR

  • FR

24

Mar
2022

Full Year 2021 Annual Report & Business Highlights

  • FR

06

May
2022

Celyad Oncology Announces First Quarter 2022 Financial Results and Recent Business Highlights

  • FR

05

Aug
2022

Celyad Oncology Reports First Half 2022 Financial Results and Recent Business Highlights

  • FR

10

Nov
2022

Celyad Oncology Announces Third Quarter 2022 Financial Results and Recent Business Highlights

  • FR


25

Mar
2021

Full Year 2020 Annual Report & Business Highlights

  • FR

31

Mar
2021

Annual Report 2020

  • FR

06

May
2021

First Quarter 2021 Financial Results and Recent Business Highlights

  • FR

04

Aug
2021

Half Year 2021 Financial Results & Business Highlights

  • FR

10

Nov
2021

Third Quarter 2021 Financial Results and Recent Business Highlights

  • FR


22

Mar
2020

Full Year 2019 Annual Report

  • FR

02

Apr
2020

Annual Report 2019

  • FR

07

May
2020

First Quarter 2020 Financial Results and Recent Business Highlights

  • FR

06

Aug
2020

Half Year 2020 Financial Results and Business Highlights

  • FR

10

Nov
2020

Third Quarter 2020 Financial Results and Recent Business Highlights

  • FR


28

Mar
2019

Full Year 2018 Financial and Operating Results

  • FR

05

Apr
2019

Annual Report 2018

  • FR

09

May
2019

First Quarter 2019 Financial Results and Recent Business Highlights

  • FR

22

Aug
2019

Interim Financial Report H1.2019

  • FR

19

Nov
2019

Celyad Announces Third Quarter 2019 Financial Results and Recent Business Highlights

  • FR


22

Mar
2018

Full year 2017 Financial and Operating Results

  • FR

06

Apr
2018

Annual report 2017

  • FR

15

May
2018

First Quarter 2018 Financial Results and Recent Business Highlights

  • FR

23

Aug
2018

First Half 2018 Financial Results and Operational Progress

  • FR

21

Nov
2018

Third Quarter 2018 Business Update

  • FR


23

Mar
2017

Celyad Reports 2016 Financial and Operating Results

  • FR

19

May
2017

First Quarter 2017 Business Update

  • FR

26

May
2017

Celyad’s Annual Report 2016

  • FR

29

Aug
2017

First Half 2017 Financial statements and operational progress

  • FR


06

Apr
2016

AR 2015 Annual report

  • EN

20

May
2016

Q1 2016 Business Update

  • EN

25

Aug
2016

Celyad 2016 First Half Year Report

  • FR

18

Nov
2016

Q3 2016 Business Update

  • FR


30

Jun
2015

H1 2015 Interim Financial Report

  • FR

19

Nov
2015

Q3 2015 Business Update

  • FR

SEC Filings

Filter


« First«...45678...»Last »
Filing Date Form Description Filing Group Downloads
January 20, 2021 6-K Report of foreign issuer Current reports
  • PDF
  • RTF
  • XLS
  • HTML
  • XBRL
January 20, 2021 6-K Report of Foreign Issuer Current reports
  • PDF
  • RTF
  • XLS
  • HTML
  • XBRL
January 7, 2021 424B5 Prospectus filed pursuant to Rule 424(b)(5) Other
  • PDF
  • RTF
  • XLS
  • HTML
  • XBRL
December 7, 2020 6-K Report of Foreign Issuer
  • PDF
  • RTF
  • XLS
  • HTML
  • XBRL
November 12, 2020 6-K Report of Foreign issuer
  • PDF
  • RTF
  • XLS
  • HTML
  • XBRL
September 29, 2020 6-K Report of Foreign Issuer Current reports
  • PDF
  • RTF
  • XLS
  • HTML
  • XBRL

« First«...45678...»Last »

Regulated Information

Filter

Request for proposal of external statutory Auditor mandate

Uncategorized | December 20th, 2022

Interim Financial Report – First Half 2022

Uncategorized | August 5th, 2022

RAPPORT FINANCIER INTERMEDIAIRE

Uncategorized | August 5th, 2022

Footer

Celyad Oncology

Celyad Oncology Logo
  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.

  • Cookie Policy |
  • Privacy Policy |
  • Terms of Use